Efficacy of Transcranial Direct Current Stimulation to Improve Insight in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

BACKGROUND AND HYPOTHESIS Impaired insight into the illness and its consequences is associated with poor outcomes in schizophrenia. While transcranial direct current stimulation (tDCS) may represent a potentially effective treatment strategy to relieve various symptoms of schizophrenia, its impact on insight remains unclear. To investigate whether tDCS would modulate insight in patients with schizophrenia, we undertook a meta-analysis based on results from previous RCTs that investigated the clinical efficacy of tDCS. We hypothesize that repeated sessions of tDCS will be associated with insight improvement among patients. STUDY DESIGN PubMed and ScienceDirect databases were systematically searched to identify RCTs that delivered at least 10 tDCS sessions in patients with schizophrenia. The primary outcome was the change in insight score, assessed by the Positive and Negative Syndrome Scale (PANSS) item G12 following active tDCS sessions as opposed to sham stimulation. Effect sizes were calculated for all studies and pooled using a random-effects model. Meta-regression and subgroup analyses were conducted. STUDY RESULTS Thirteen studies (587 patients with schizophrenia) were included. A significant pooled effect size (g) of -0.46 (95% CI [-0.78; -0.14]) in favor of active tDCS was observed. Age and G12 score at baseline were identified as significant moderators, while change in total PANSS score was not significant. CONCLUSIONS Ten sessions of active tDCS with either frontotemporoparietal or bifrontal montage may improve insight into the illness in patients with schizophrenia. The effect of this treatment could contribute to the beneficial outcomes observed in patients following stimulation.

[1]  A. Brunoni,et al.  Adjunctive tDCS for treatment-refractory auditory hallucinations in schizophrenia: A meta-analysis of randomized, double-blinded, sham-controlled studies. , 2022, Asian journal of psychiatry.

[2]  J. Brunelin,et al.  Improvement of Insight with Non-Invasive Brain Stimulation in Patients with Schizophrenia: A Systematic Review , 2021, Journal of clinical medicine.

[3]  M. Leboyer,et al.  Comparison of three scales (BIS, SUMD and BCIS) for measuring insight dimensions and their evolution after one-year of follow-up: Findings from the FACE-SZ Cohort , 2021, Psychiatry Research.

[4]  J. Lindenmayer,et al.  Noninvasive direct current stimulation for schizophrenia: a review , 2021, Current opinion in psychiatry.

[5]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[6]  W. Chan,et al.  The effects of transcranial direct current stimulation (tDCS) on clinical symptoms in schizophrenia: A systematic review and meta-analysis. , 2020, Asian journal of psychiatry.

[7]  L. Hahn,et al.  A qualitative study of medication adherence amongst people with schizophrenia. , 2020, Archives of psychiatric nursing.

[8]  G. Learmonth,et al.  Is the “end‐of‐study guess” a valid measure of sham blinding during transcranial direct current stimulation? , 2020, bioRxiv.

[9]  G. Ungvari,et al.  Poor Insight in Schizophrenia Patients in China: a Meta-Analysis of Observational Studies , 2020, Psychiatric Quarterly.

[10]  Julian Pt Higgins,et al.  Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments , 2020, Research synthesis methods.

[11]  Hsin-An Chang,et al.  Modulation of self-appraisal of illness, medication adherence, life quality and autonomic functioning by transcranial direct current stimulation in schizophrenia patients , 2020, Clinical Neurophysiology.

[12]  A. Brunoni,et al.  Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial. , 2020, JAMA psychiatry.

[13]  Hsin-An Chang,et al.  Examining bi-anodal transcranial direct current stimulation (tDCS) over bilateral dorsolateral prefrontal cortex coupled with bilateral extracephalic references as a treatment for negative symptoms in non-acute schizophrenia patients: A randomized, double-blind, sham-controlled trial , 2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[14]  John M. Davis,et al.  Effects of transcranial direct current stimulation on cognition and symptoms in Chinese patients with schizophrenia✰ , 2019, Psychiatry Research.

[15]  J. Mattingley,et al.  Modulating brain activity and behaviour with tDCS: Rumours of its death have been greatly exaggerated , 2019, Cortex.

[16]  R. Lenroot,et al.  Preliminary findings of four-week, task-based anodal prefrontal cortex transcranial direct current stimulation transferring to other cognitive improvements in schizophrenia , 2019, Psychiatry Research.

[17]  B. Pollock,et al.  Modulation of brain activity with transcranial direct current stimulation: Targeting regions implicated in impaired illness awareness in schizophrenia , 2019, European Psychiatry.

[18]  F. Van Overwalle,et al.  The posterior Cerebellum is involved in constructing Social Action Sequences: An fMRI Study , 2019, Scientific Reports.

[19]  D. Javitt,et al.  Significant improvement in treatment resistant auditory verbal hallucinations after 5 days of double-blind, randomized, sham controlled, fronto-temporal, transcranial direct current stimulation (tDCS): A replication/extension study , 2019, Brain Stimulation.

[20]  Hsin-An Chang,et al.  Enhancement of cognitive insight and higher-order neurocognitive function by fronto-temporal transcranial direct current stimulation (tDCS) in patients with schizophrenia , 2019, Schizophrenia Research.

[21]  Á. Pascual-Leone,et al.  Sham tDCS: A hidden source of variability? Reflections for further blinded, controlled trials , 2019, Brain Stimulation.

[22]  B. Pollock,et al.  Impaired illness awareness in schizophrenia and posterior corpus callosal white matter tract integrity , 2019, npj Schizophrenia.

[23]  B. Pollock,et al.  A meta-analysis of transcranial direct current stimulation for schizophrenia: "Is more better?" , 2019, Journal of psychiatric research.

[24]  J. Lindenmayer,et al.  Transcranial direct-current stimulation in ultra-treatment-resistant schizophrenia , 2019, Brain Stimulation.

[25]  A. Bose,et al.  High-definition transcranial direct current simulation (HD-tDCS) for persistent auditory hallucinations in schizophrenia. , 2018, Asian journal of psychiatry.

[26]  M. Nitsche,et al.  Physiology of Transcranial Direct Current Stimulation , 2018, The journal of ECT.

[27]  C. Yeh,et al.  The Effects of Add-on Fronto-Temporal Transcranial Direct Current Stimulation (tDCS) on Auditory Verbal Hallucinations, Other Psychopathological Symptoms, and Insight in Schizophrenia: A Randomized, Double-Blind, Sham-Controlled Trial , 2018, The international journal of neuropsychopharmacology.

[28]  J. Shim,et al.  Adjunct transcranial direct current stimulation improves cognitive function in patients with schizophrenia: A double-blind 12-week study , 2018, Schizophrenia Research.

[29]  S. Koops,et al.  Treating auditory hallucinations with transcranial direct current stimulation in a double-blind, randomized trial , 2018, Schizophrenia Research.

[30]  Flavio Fröhlich,et al.  Randomized trial of transcranial alternating current stimulation for treatment of auditory hallucinations in schizophrenia , 2018, European Psychiatry.

[31]  M. Bozzali,et al.  Lobular patterns of cerebellar resting‐state connectivity in adults with Autism Spectrum Disorder , 2018, The European journal of neuroscience.

[32]  J. Vohs,et al.  Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments , 2018, World psychiatry : official journal of the World Psychiatric Association.

[33]  S. Rossi,et al.  Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines , 2017, Clinical Neurophysiology.

[34]  R. Rosenheck,et al.  Factors associated with complete discontinuation of medication among patients with schizophrenia in the year after hospital discharge , 2017, Psychiatry Research.

[35]  M. Sajatovic,et al.  Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness , 2017, Patient preference and adherence.

[36]  P. Boyle,et al.  Anosognosia in Dementia , 2016, Current Neurology and Neuroscience Reports.

[37]  P. Falkai,et al.  Prefrontal Transcranial Direct Current Stimulation for Treatment of Schizophrenia With Predominant Negative Symptoms: A Double-Blind, Sham-Controlled Proof-of-Concept Study. , 2016, Schizophrenia bulletin.

[38]  M. Nitsche,et al.  Impact of antipsychotic medication on transcranial direct current stimulation (tDCS) effects in schizophrenia patients , 2016, Psychiatry Research.

[39]  Renaud Jardri,et al.  Effects of Fronto-Temporal Transcranial Direct Current Stimulation on Auditory Verbal Hallucinations and Resting-State Functional Connectivity of the Left Temporo-Parietal Junction in Patients With Schizophrenia , 2015, Schizophrenia bulletin.

[40]  P. McGuire,et al.  Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials. , 2015, Schizophrenia bulletin.

[41]  M. Keshavan,et al.  Neurobiology of insight deficits in schizophrenia: An fMRI study , 2015, Schizophrenia Research.

[42]  L. Mete,et al.  The impact of insight on social functioning in patients with schizophrenia , 2015, The International journal of social psychiatry.

[43]  O. Carter,et al.  Quantitative Review Finds No Evidence of Cognitive Effects in Healthy Populations From Single-session Transcranial Direct Current Stimulation (tDCS) , 2015, Brain Stimulation.

[44]  B. Pollock,et al.  Illness denial in schizophrenia spectrum disorders , 2015, Human brain mapping.

[45]  B. Pollock,et al.  Impaired insight into illness and cognitive insight in schizophrenia spectrum disorders: Resting state functional connectivity , 2014, Schizophrenia Research.

[46]  P. Fitzgerald,et al.  A Negative Pilot Study of Daily Bimodal Transcranial Direct Current Stimulation in Schizophrenia , 2014, Brain Stimulation.

[47]  T. Rajji,et al.  The effects of aging on insight into illness in schizophrenia: a review , 2014, International journal of geriatric psychiatry.

[48]  C. Schönfeldt-Lecuona,et al.  A systematic review of the clinical relevance of repetitive transcranial magnetic stimulation , 2014, Acta psychiatrica Scandinavica.

[49]  S. Leucht.  Measurements of response, remission, and recovery in schizophrenia and examples for their clinical application. , 2014, The Journal of clinical psychiatry.

[50]  Michal Lavidor,et al.  Prefrontal oscillatory stimulation modulates access to cognitive control references in retrospective metacognitive commentary , 2014, Clinical Neurophysiology.

[51]  J. Vohs,et al.  Poor insight into schizophrenia: contributing factors, consequences and emerging treatment approaches , 2013, Expert review of neurotherapeutics.

[52]  B. Pollock,et al.  Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia , 2013, Human brain mapping.

[53]  A. Aleman,et al.  Changes in insight during treatment for psychotic disorders: A meta-analysis , 2013, Schizophrenia Research.

[54]  Y. Levkovitz,et al.  Comparison of insight among schizophrenia and bipolar disorder patients in remission of affective and positive symptoms: Analysis and critique , 2012, European Psychiatry.

[55]  Esteban Medina,et al.  Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder , 2012, Patient preference and adherence.

[56]  Mohamed Saoud,et al.  Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. , 2012, The American journal of psychiatry.

[57]  P. Santaguida,et al.  Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions , 2012 .

[58]  O. Andreassen,et al.  Predictors of medication adherence in patients with schizophrenia and bipolar disorder , 2012, Acta psychiatrica Scandinavica.

[59]  Ó. Vilarroya,et al.  Gray matter volume deficits and correlation with insight and negative symptoms in first‐psychotic‐episode subjects , 2011, Acta psychiatrica Scandinavica.

[60]  B. Ardekani,et al.  White matter integrity and lack of insight in schizophrenia and schizoaffective disorder , 2011, Schizophrenia Research.

[61]  Takefumi Suzuki.  Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review. , 2011, Psychopharmacology bulletin.

[62]  M. Ridding,et al.  Determinants of the induction of cortical plasticity by non‐invasive brain stimulation in healthy subjects , 2010, The Journal of physiology.

[63]  J. Haro,et al.  Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia , 2010, Psychiatry Research.

[64]  S. Sengupta,et al.  Psychopathology, insight and compliance in schizophrenia , 2009, Irish Journal of Psychological Medicine.

[65]  J. Lieberman,et al.  Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. , 2009, Schizophrenia bulletin.

[66]  A. Fu,et al.  Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States , 2007, Current medical research and opinion.

[67]  C. Ko,et al.  Changes in insight among patients with bipolar I disorder: a 2-year prospective study. , 2007, Bipolar disorders.

[68]  N. Tarrier,et al.  Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. , 2007, The Journal of clinical psychiatry.

[69]  M. Keshavan,et al.  Neurobiological underpinnings of insight deficits in schizophrenia , 2007, International review of psychiatry.

[70]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[71]  Dan J Stein,et al.  Obsessive-compulsive disorder with poor insight. , 2002, Comprehensive psychiatry.

[72]  M. Nitsche,et al.  Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation , 2000, The Journal of physiology.

[73]  A. David,et al.  A comparative study of insight scales and their relationship to psychopathological and clinical variables , 1998, Psychological Medicine.

[74]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[75]  J. Gomesa,et al.  ff ects of transcranial direct current stimulation on working memory and negative symptoms in schizophrenia : a phase II randomized sham-controlled trial , 2018 .

[76]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.